152 related articles for article (PubMed ID: 2058871)
21. Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective.
Yarzebski J; Col N; Pagley P; Savageau J; Gore J; Goldberg R
Am Heart J; 1996 Jan; 131(1):43-50. PubMed ID: 8554018
[TBL] [Abstract][Full Text] [Related]
22. The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy. Israeli Thrombolytic Survey Group.
Behar S; Gottlieb S; Hod H; Benari B; Narinsky R; Pauzner H; Rechavia E; Faibel HE; Katz A; Roth A; Goldhammer E; Freedberg NA; Rougin N; Kracoff O; Shapira C; Jafari J; Lotan C; Daka F; Weiss T; Kanetti M; Klutstein M; Rudnik L; Barasch E; Mahul N; Blondheim D
Am J Med; 1996 Aug; 101(2):184-91. PubMed ID: 8757359
[TBL] [Abstract][Full Text] [Related]
23. Interaction between arrival time and thrombolytic treatment in determining early outcome of acute myocardial infarction.
Wilkinson J; Foo K; Sekhri N; Cooper J; Suliman A; Ranjadayalan K; Timmis AD
Heart; 2002 Dec; 88(6):583-6. PubMed ID: 12433884
[TBL] [Abstract][Full Text] [Related]
24. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Harrington RA; Sane DC; Califf RM; Sigmon KN; Abbottsmith CW; Candela RJ; Lee KL; Topol EJ
J Am Coll Cardiol; 1994 Mar; 23(4):891-8. PubMed ID: 8106694
[TBL] [Abstract][Full Text] [Related]
25. Thrombolytic therapy of acute myocardial infarction. Keeping the unfulfilled promises.
Doorey AJ; Michelson EL; Topol EJ
JAMA; 1992 Dec; 268(21):3108-14. PubMed ID: 1433742
[TBL] [Abstract][Full Text] [Related]
26. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
[TBL] [Abstract][Full Text] [Related]
27. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Van de Werf F
J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802
[TBL] [Abstract][Full Text] [Related]
28. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators.
Pfeffer MA; Moyé LA; Braunwald E; Basta L; Brown EJ; Cuddy TE; Dagenais GR; Flaker GO; Geltman EM; Gersh BJ
JAMA; 1991 Jul 24-31; 266(4):528-32. PubMed ID: 2061979
[TBL] [Abstract][Full Text] [Related]
29. [What thrombolytic rate can be realized in acute myocardial infarct? Results of the Oltner Heart Emergency Study].
Gaillet R; Saner H; Pfister R; Pirovino M
Schweiz Med Wochenschr; 1998 May; 128(20):775-83. PubMed ID: 9642753
[TBL] [Abstract][Full Text] [Related]
30. The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction.
Cohen M; Gensini GF; Maritz F; Gurfinkel EP; Huber K; Timerman A; Santopinto J; Corsini G; Terrosu P; Joulain F
J Thromb Thrombolysis; 2005 Jun; 19(3):155-61. PubMed ID: 16082602
[TBL] [Abstract][Full Text] [Related]
31. The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial.
Althouse R; Maynard C; Cerqueira MD; Olsufka M; Ritchie JL; Kennedy JW
Am J Cardiol; 1990 Dec; 66(19):1298-303. PubMed ID: 2123073
[TBL] [Abstract][Full Text] [Related]
32. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
Barron HV; Bowlby LJ; Breen T; Rogers WJ; Canto JG; Zhang Y; Tiefenbrunn AJ; Weaver WD
Circulation; 1998 Mar; 97(12):1150-6. PubMed ID: 9537341
[TBL] [Abstract][Full Text] [Related]
33. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial.
McCullough PA; O'Neill WW; Graham M; Stomel RJ; Rogers F; David S; Farhat A; Kazlauskaite R; Al-Zagoum M; Grines CL
J Am Coll Cardiol; 1998 Sep; 32(3):596-605. PubMed ID: 9741499
[TBL] [Abstract][Full Text] [Related]
34. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
[TBL] [Abstract][Full Text] [Related]
35. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
[TBL] [Abstract][Full Text] [Related]
36. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
37. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
[TBL] [Abstract][Full Text] [Related]
38. Review of Emergency Department thrombolytic therapy and changes in inpatient mortality of acute myocardial infarction on the NSW Central Coast 1986 to 1994-96.
Hooi H
Aust N Z J Med; 1999 Aug; 29(4):505-11. PubMed ID: 10868528
[TBL] [Abstract][Full Text] [Related]
39. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
Cucherat M; Bonnefoy E; Tremeau G
Cochrane Database Syst Rev; 2003; (3):CD001560. PubMed ID: 12917910
[TBL] [Abstract][Full Text] [Related]
40. [Use of thrombolytic treatment in patients with acute myocardial infarction in Spain. Observations from the PRIAMHO study].
Bosch X; Sambola A; Arós F; López-Bescós L; Mancisidor X; Illa J; Claramonte R
Rev Esp Cardiol; 2000 Apr; 53(4):490-501. PubMed ID: 10760231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
